copper-64[Cu-64]-labeled LNTH-1363S
Phase 1- Indications
- Diagnostic imaging
Company intelligence / Profile preview
PharmaLogic operates one of North America’s largest networks for the development, manufacturing, distribution, and commercialization of diagnostic and therapeutic radiopharmaceuticals. It supports both investigational trials/new drug applications as well as commercial supply. The company recently expanded its manufacturing footprint with new facilities in Los Angeles and Salt Lake City. It also announced the acquisition of Agilera to strengthen its global expertise in radiotherapeutics. No specific clinical trial results are disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaLogic.